Pihlajalinna Oyj operates in the Offices & clinics of medical doctors sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Pihlajalinna Oyj with three other
health care providers in Europe:
Aevis Victoria SA
sales of 582.49 million Swiss Francs [US$579.02 million]
of which 86%
Ambea Ab (Publ)
(5.82 billion Swedish Kronor [US$640.17 million]
of which 49%
was Nytida), and
Luz Saude SA
based in Portugal
(483.90 million Euro [US$547.40 million]
of which 79%
was Private Health Care).
Pihlajalinna Oyj reported sales of 423.98 million Euro (US$479.62 million)
December of 2017.
increase of 6.2%
versus 2016, when the company's sales were 399.09 million Euro.
Sales at Pihlajalinna Oyj have increased during each of the previous five years
(and since 2012, sales have increased a total of 797%).
Sales of C and S saw an increase
8.4% in 2017, from
213.34 million Euro to 231.33 million Euro.